semaglutide news today october 2025 State tying weight loss drug use to new program | Health & Human Services Rising use of GLP-1 medications
Description
People are losing 15, 20 percent of their body weight
A recent study showed promising weight loss results in those with Type 2 diabetes.
PlexusDx provides compounded semaglutide injections with clear dosing guidance from licensed 503A pharmacies
Learn what evidence shows about colorectal cancer risk.
GLP-1 medication users: those on semaglutide/tirzepatide experiencing slower gastric emptying may benefit from enzyme support (consult physician)
